chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Daily headaches; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 30Mar2021 at 13:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included fruit allergy to avocado. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 20:00, the patient experienced daily headaches. The patient did not receive any treatment for event. The clinical outcome of the event daily headaches was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: I can not move my arm pain traveling up and down arm into back area.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 16:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid disorder not otherwise specified (thyroid problem) started on an unknown date. Concomitant medications included loratadine (CLARITIN) and levothyroxine (MANUFACTURER UNKNOWN)  both for an unknown indication from an unknown dates. The patient previously received aspirin on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 08:00 the patient was not able to move her arm, pain traveling up and down arm into back area. The patient consulted the doctor for which he said this was normal but the patient was not sure about it. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event can not move her arm pain traveling up and down arm into back area was not recovered at the time of this report.   No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo type symptoms; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in the left arm on 01Apr2021 at 09:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 15:30, in the afternoon, the patient experienced vertigo type symptoms. The event resulted in doctor or other healthcare professional office/clinic visit. The patient was given information regarding vertigo and treatment included chiropractic adjustment. The clinical outcome of the event vertigo type symptoms was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Colitis ulcerative, Enteritis, Gastrointestinal pain
Clinical narrative: due to ulcerative colitis, appears to have triggered inflammation in bowel; due to ulcerative colitis, appears to have triggered inflammation in bowel; severe stomach intestinal cramping; Extreme lower back pain; This is a spontaneous report from a non-contactable consumer (patient). A 55-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm, on 30Mar2021 at 13:45 for COVID-19 immunisation.  Medical history included ulcerative colitis. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 04Mar2021 (at the age of 55-years-old), in the left arm, for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced due to ulcerative colitis, appears to have triggered inflammation in bowel, extreme lower back pain, and severe stomach intestinal cramping on 01Apr2021. The clinical course was reported as follows: The patient experienced extreme lower back pain approximately within 40 hours after vaccination. Also, severe stomach intestinal cramping occurred. Due to the ulcerative colitis, it appears to have triggered inflammation in the bowel. The clinical outcome of ulcerative colitis, appears to have triggered inflammation in bowel, extreme lower back pain, and severe stomach intestinal cramping was unknown. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Diarrhoea, Headache, Lip pruritus
Clinical narrative: Tongue tingling; inner lip swelling sensation; inner lips itchy; Mild tightness in throat and bronchial; Red dot with pink circle on forehead; Shoulder pain; Diarhea; Slight headache; mild temperature 98.4 two days; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8732) via an unspecified route of administration in the left arm on 28Mar2021 at 13:30(at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included unspecified conditions. The patient had unspecified allergies to medication, food or other products. Concomitant medications included calcium (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN), potassium (MANUFACTURER UNKNOWN), vitamin d nos (VIT D) and vitamin b complex (MANUFACTURER UNKNOWN) all from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021, 2minutes after the vaccination, the patient experienced tongue tingling, inner lips itchy swelling sensation. On the same day, 5 minutes after the vaccination, mild tightness in the throat and bronchial. On the same day, 1 hour after the vaccination, the patient experienced a slight headache and mild temp 98.4 usually her temperature was 97.3. On the same day, 3 hours after the vaccination, the patient experienced red dot with pink circle on forehead and shoulder pain. On the same day 18 hours after the vaccination, the patient experienced diarrhoea. On 28Mar2021, the patient underwent body temperature and the result was mild temperature 98.4. The patient was not treated with any medications for the events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the events tongue tingling, inner lips itchy swelling sensation, mild tightness in throat and bronchial, a red dot with a pink circle on the forehead was recovered on 28Mar2021 after the duration of 1 hour. The clinical outcome of the events shoulder pain, diarrhoea, slight headache and mild temperature 98.4 was recovered on an unknown date.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Paraesthesia oral, Petechiae, Pyrexia, Throat tightness
Clinical narrative: Tongue tingling; inner lip swelling sensation; inner lips itchy; Mild tightness in throat and bronchial; Red dot with pink circle on forehead; Shoulder pain; Diarhea; Slight headache; mild temperature 98.4 two days; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8732) via an unspecified route of administration in the left arm on 28Mar2021 at 13:30(at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included unspecified conditions. The patient had unspecified allergies to medication, food or other products. Concomitant medications included calcium (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN), potassium (MANUFACTURER UNKNOWN), vitamin d nos (VIT D) and vitamin b complex (MANUFACTURER UNKNOWN) all from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021, 2minutes after the vaccination, the patient experienced tongue tingling, inner lips itchy swelling sensation. On the same day, 5 minutes after the vaccination, mild tightness in the throat and bronchial. On the same day, 1 hour after the vaccination, the patient experienced a slight headache and mild temp 98.4 usually her temperature was 97.3. On the same day, 3 hours after the vaccination, the patient experienced red dot with pink circle on forehead and shoulder pain. On the same day 18 hours after the vaccination, the patient experienced diarrhoea. On 28Mar2021, the patient underwent body temperature and the result was mild temperature 98.4. The patient was not treated with any medications for the events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the events tongue tingling, inner lips itchy swelling sensation, mild tightness in throat and bronchial, a red dot with a pink circle on the forehead was recovered on 28Mar2021 after the duration of 1 hour. The clinical outcome of the events shoulder pain, diarrhoea, slight headache and mild temperature 98.4 was recovered on an unknown date.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Facial pain, Swelling face, Taste disorder, Tinnitus
Clinical narrative: left side of face started swelling and painful to touch. Both side are swollen now but left way worse than right.; left side of face started swelling and painful to touch. Both side are swollen now but left way worse than right.; Left ear feels plugged and ringing in ears.; Senses of Taste is greatly effected; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm right on 27Mar2021 at 11:00(at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included gluten sensitivity, allergic to formaldehyde and preservatives. Concomitant medications were not reported. The patient previously took Erythromycin on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 the patient experienced left ear feels plugged and ringing in ears and senses of taste is greatly effected. On 02Apr2021 the patient experienced left side of face started swelling and painful to touch. Both sides are swollen now but left way worse than right. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the event left side of face started swelling, painful to touch, left ear feels plugged and ringing in ears and senses of taste is greatly effected were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysphagia, Headache
Clinical narrative: Dizziness; Difficulty swallowing; Headache; This is a spontaneous report from a contactable consumer, the patient. A 63-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 05Apr2021 at 18:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and food allergy (almonds). The patient did not receive any concomitant medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced dizziness, difficulty swallowing and headache. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events dizziness, difficulty swallowing and headache were unknown.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Dizziness, Fatigue, Food craving, Hypobarism
Clinical narrative: Woozy; Very dehydrated; Craving carbs; Felt like head was spinning; Felt like the patient was at high altitude for two days; Extremely tired; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the arm left on 31Mar2021 at 13:15(at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, migraine, hashimotos disease, factor v leiden mutation and allergy to large of chemicals (contact dermatitis). Concomitant medications included levothyroxine sodium (SYNTHROID), valaciclovir hydrochloride (VALTREX), cetirizine hydrochloride (ZYRTEC) and gabapentin (MANUFACTURER UNKNOWN) all from unknown date taken for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 13:15, the patient felt like she was at high altitude for two days (felt fine by 02Apr2021 Friday morning), woozy, very dehydrated, craving carbs and extremely tired. The wooziness hit within 5 min of getting the shot. The patient felt like head was spinning the whole drive home. The patient did not receive any treatment for the events. Events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events extremely tired(fatigue), woozy(Dizziness), very dehydrated(dehydration), craving carbs(food craving) and felt like head was spinning(vertigo)was recovered on an unknown date in 2021. The clinical outcome of the event felt like the patient was at high altitude(hypobarism) for two days was recovered on 02Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Woozy; Very dehydrated; Craving carbs; Felt like head was spinning; Felt like the patient was at high altitude for two days; Extremely tired; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the arm left on 31Mar2021 at 13:15(at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, migraine, hashimotos disease, factor v leiden mutation and allergy to large of chemicals (contact dermatitis). Concomitant medications included levothyroxine sodium (SYNTHROID), valaciclovir hydrochloride (VALTREX), cetirizine hydrochloride (ZYRTEC) and gabapentin (MANUFACTURER UNKNOWN) all from unknown date taken for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 13:15, the patient felt like she was at high altitude for two days (felt fine by 02Apr2021 Friday morning), woozy, very dehydrated, craving carbs and extremely tired. The wooziness hit within 5 min of getting the shot. The patient felt like head was spinning the whole drive home. The patient did not receive any treatment for the events. Events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events extremely tired(fatigue), woozy(Dizziness), very dehydrated(dehydration), craving carbs(food craving) and felt like head was spinning(vertigo)was recovered on an unknown date in 2021. The clinical outcome of the event felt like the patient was at high altitude(hypobarism) for two days was recovered on 02Apr2021.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: a week after the second shot I developed Shingles. My father in law had the same thing happen to him; This is a spontaneous report from a contactable consumer. This consumer reported for a male patient (father-in-law).  A male patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, after the vaccination, the patient developed Shingles. The outcome of the event was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021365144 same reporter/drug/event, different patient
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Hypoaesthesia, Nausea
Clinical narrative: Chills; Body aches; Nausea; Numb arm; Temp 103.2 (fever); Headache; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 03Apr2021 at 08:15(at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 20:30, the patient experienced nausea, temp 103.2 (fever), chills, headache, body aches and numb arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if patient received any treatment for the events. On 03Apr2021, the patient underwent tests and procedures which include body temperature and the result was 103.2 (units unspecified) .The clinical outcome of the events nausea, fever, chills, headache, general body pain and numb arm was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Chills; Body aches; Nausea; Numb arm; Temp 103.2 (fever); Headache; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 03Apr2021 at 08:15(at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 20:30, the patient experienced nausea, temp 103.2 (fever), chills, headache, body aches and numb arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if patient received any treatment for the events. On 03Apr2021, the patient underwent tests and procedures which include body temperature and the result was 103.2 (units unspecified) .The clinical outcome of the events nausea, fever, chills, headache, general body pain and numb arm was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Fatigue
Clinical narrative: Fatigue; Loss of taste; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the left arm on 05Apr2021 at 09:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and penicillin allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 05Apr2021 at 19:45, the patient experienced fatigue and loss of taste. The events did not result in a doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events experienced. The clinical outcome of the events fatigue and loss of taste was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, SARS-CoV-2 test, Skin warm
Clinical narrative: Hands are super itchy. Like distractingly itchy.; They are also warmer to the touch; Slightly redder; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 19:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On an unknown date post vaccination, the patient underwent nasal swab and tested negative. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 06:00, the patient experienced hands were super itchy, like distractingly itchy. The patient had never experienced this type of sensation in life. They were also warmer to the touch and slightly redder. the patient assumed it would just kinda go away but it really hadn't and it got the patient slightly worried about the second dose. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event hands were super itchy, warmer to touch and slightly redder was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Dry eye, Fatigue
Clinical narrative: Dizziness; Dry eyes; Headache; Nausea; Sweats; Chills; Joint pain; Rib pain; Pain at injection site; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 02Apr2021 at 15:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included arrhythmia, high cholesterol, arthritis and COVID-19. The patient had a history of allergy to peanuts, nuts and fish. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 15:15, the patient experienced headache, dry eyes, dizziness, nausea, chills, sweats, joint pain, pain at injection site, rib pain and fatigue. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events dizziness, dry eyes, headache, nausea, sweats, chills, joint pain, rib pain, pain at injection site and fatigue were recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Musculoskeletal chest pain, Nausea, Vaccination site pain
Clinical narrative: Dizziness; Dry eyes; Headache; Nausea; Sweats; Chills; Joint pain; Rib pain; Pain at injection site; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 02Apr2021 at 15:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included arrhythmia, high cholesterol, arthritis and COVID-19. The patient had a history of allergy to peanuts, nuts and fish. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 15:15, the patient experienced headache, dry eyes, dizziness, nausea, chills, sweats, joint pain, pain at injection site, rib pain and fatigue. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events dizziness, dry eyes, headache, nausea, sweats, chills, joint pain, rib pain, pain at injection site and fatigue were recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: red rash outbreak on neck and chest; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 02Apr2021 at 14:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included kidney stones, gallstones and depression. Concomitant medications included venlafaxine (MANUFACTURER UNKNOWN), lamotrigine(MANUFACTURER UNKNOWN), valacyclovir (MANUFACTURER UNKNOWN). The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 12Mar2021 at 15:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 12:30 the patient experienced a red rash outbreak on the neck and chest. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visits, and the emergency room/department or urgent care. The clinical outcome of the event red rash outbreak on the neck and chest was not recovered at the time of the report.  No follow-up attempts are needed; information about the lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Tinnitus
Clinical narrative: Trouble breathing and tinnitus; Trouble breathing and tinnitus; This is a spontaneous report from a contactable consumer.  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced trouble breathing and tinnitus on an unspecified date. It was reported that Caller had called to report on her experience with the 1st dose of Pfizer Covid 19 vaccine and had been seen at an emergency clinic for trouble with breathing and tinnitus. It was reported that while she was in the emergency clinic there was a woman there 1 hour before her that also got Pfizer and had the same issue as she did. No further information was obtained or provided. The outcome of events was unknown.  No follow up attempts are possible. Information about lot/batch number cannot be requested.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Red itchy raised splotches each about the size of a quarter, one above and one below injection site.; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 05Mar2021 at 08:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included PCOS, eczema, celiac, seasonal allergies and known allergies to gluten, latex and strawberries. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021, the patient experienced red itchy raised splotches each about the size of a quarter, one above and one below injection site which began on day 6 and lasted till day 9. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event red itchy raised splotches each about the size of a quarter, one above and one below injection site was resolved on 14Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Headache, Muscle twitching, Pain in extremity, SARS-CoV-2 test
Clinical narrative: Facial twitching; Pain in arm; Headache; This is a spontaneous report received from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150 7121) via an unspecified route of administration in the left arm on 02Apr2021 at 11:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included vitamin d deficiency, iron deficiency anemia and seafood allergy. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) taken roughly 2 weeks before vaccine, for unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19.The patient had not received any other vaccines within four weeks prior to COVID vaccine.  Since the vaccination, the patient had not been tested for COVID-19.  On 02Apr2021, patient had soreness in arm and headache. The patient reported that the soreness in arm that increased in intensity on 2nd day (now OK) and light but persistent headache over 3 days (now OK). On 04Apr2021, the patient experienced facial twitching. She reported that facial twitching started the 2nd day and onwards (today is the 4th day and was still occurring). The patient underwent COVID-19 test (blood test) on an unknown date in Nov2020 and the test result was negative. The patient did not receive any treatment for the reported adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of pain in arm and headache was recovering at the time of this report. The clinical outcome of the event facial twitching was ongoing at the time of this report.  No follow-up attempts are needed. No further information is expected
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Myalgia, Vaccination site pain
Clinical narrative: fatigue; injection site pain; muscle aches; head aches; Vertigo; dizziness; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the arm left on 30Mar2021 at 15:00(at the age of 34-year-old), as a single dose for COVID-19 immunisation. Medical history included sleep apnea. The patient received birth control, vitamins, cbd within two weeks of vaccination. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199), as a single dose for covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 at 14:00, the patient experienced fatigue, injection site pain, muscle aches, headaches, vertigo and dizziness. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, injection site pain, muscle aches, headaches, vertigo and dizziness was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: fatigue; injection site pain; muscle aches; head aches; Vertigo; dizziness; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the arm left on 30Mar2021 at 15:00(at the age of 34-year-old), as a single dose for COVID-19 immunisation. Medical history included sleep apnea. The patient received birth control, vitamins, cbd within two weeks of vaccination. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199), as a single dose for covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 at 14:00, the patient experienced fatigue, injection site pain, muscle aches, headaches, vertigo and dizziness. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, injection site pain, muscle aches, headaches, vertigo and dizziness was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Migraine, Vertigo
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 18Mar2021 at 15:00 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure, cholesterol, fusion surgery on c6/c7, known allergy to cantaloupe and known seasonal allergies. Concomitant medications included lisinopril 10mg (MANUFACTURER UNKNOWN), rosuvastatin 5mg (MANUFACTURER UNKNOWN), and cyclobenzaprine (MANUFACTURER UNKNOWN); all for unknown indication from unknown dates. The patient previously took azithromycin (MANUFACTURER UNKNOWN) for unknown indication from unknown date and experienced drug allergy.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 18Mar2021 the patient experienced mild headache for the first 2 days. On 21Mar2021, on the third day, the patient experienced severe migraine. On an unknown date in 2021 the patient experienced vertigo periodically. The patient reported to have had hazy and mild headache lasting since the vaccine. The headache "comes and goes" as reported. The patient had no fever. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department, or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events headache, migraine, and vertigo were unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Head titubation, Illness, Vision blurred
Clinical narrative: sick; blurry vision; head bobbing; This is a spontaneous report from a contactable consumer, the patient. A 64-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration on the right arm on 19Mar2021 at 12:00 as a single dose (at the age of 64-years-old) for COVID-19 immunisation. Medical history included allergy to penicillin. Patient did not receive any concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Mar2021, the patient experienced blurry vision and head bobbing on day two and three after the vaccine. On 21Mar2021(third day), the patient got sick and she expected it. She also reported that her concern was the blurry vision and bobbing of the head. No therapeutic measures were taken as the result of adverse events. The adverse event resulted in a visit to the doctor or other healthcare professional office/clinic visit. The clinical outcomes of the events blurry vision and head bobbing were unknown at the time of this report while the event sick was resolved on 22Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Low grade fever; body chills; body aches; headache; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 03Apr2021 at 11:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medications were not reported. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 21:00, the patient experienced low grade fever, body chills, body aches and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events low grade fever, body chills, body aches and headache were resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Massive headache on left side of head; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm left on 03Apr2021 at 13:15 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included depression from an unknown date. The patient was not allergic to any medications, food, or other products. The patient received unspecified medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 16:00 the patient experienced a massive headache on the left side of the head. The patient did not receive any treatment for the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event massive headache on the left side of the head was recovered on an unknown date.   No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Fatigue, Headache, Malaise, Nasal congestion
Clinical narrative: Feeling sick/ill, under the weather.; Achey in ears; Tingling in ears; stuffy; Nasal congestion; tired; headache; This is a spontaneous report from a contactable healthcare professional. A 25-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EP7533), via intramuscular route of administration in the left arm on 01April2021 at 13:15 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient previously received doxycycline (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Concomitant medication included harmone intrauterine device (MANUFACTURER UNKNOWN) within two weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination.  On 03April2021 at 00:00, the patient experienced feeling sick or ill, under the weather, achey, tingling in ears, stuffy, nasal congestion, tiredness and headache. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office or clinic and emergency room or department or urgent care. The clinical outcome of the events feeling sick or ill, achey, tingling in ears, stuffy, nasal congestion, tiredness and headache was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Feeling sick/ill, under the weather.; Achey in ears; Tingling in ears; stuffy; Nasal congestion; tired; headache; This is a spontaneous report from a contactable healthcare professional. A 25-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EP7533), via intramuscular route of administration in the left arm on 01April2021 at 13:15 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient previously received doxycycline (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Concomitant medication included harmone intrauterine device (MANUFACTURER UNKNOWN) within two weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination.  On 03April2021 at 00:00, the patient experienced feeling sick or ill, under the weather, achey, tingling in ears, stuffy, nasal congestion, tiredness and headache. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office or clinic and emergency room or department or urgent care. The clinical outcome of the events feeling sick or ill, achey, tingling in ears, stuffy, nasal congestion, tiredness and headache was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.